Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michael

Showing results (1001-1010 of 1,306) with videos related to

Pageof 131
Sort By:
Journal of the American Heart Association|May 6, 2021
Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection FractionMelissa A Daubert, Eric Yow, Huiman X Barnhart, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Journal of Cardiac Failure|August 6, 2013
Biomarker-guided therapies in heart failure: a forum for unified strategiesMona Fiuzat, Christopher M O'Connor, Francois Gueyffier, et al.
Circulation. Heart Failure|June 3, 2015
Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart FailureTariq Ahmad, Emily C O'Brien, Phillip J Schulte, et al.
European Journal of Heart Failure|March 7, 2020
Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trialSatit Janwanishstaporn, Siting Feng, John Teerlink, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
Journal of Neurosurgery|March 9, 2019
A novel proposed grading system for cerebellar arteriovenous malformationsPeyton L Nisson, Salman A Fard, Christina M Walter, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT TrialFouad Chouairi, Justin Pacor, P Elliott Miller, et al.
BMJ Open|August 2, 2022
Factors associated with discontinuation among long-acting reversible contraceptive users: a multisite prospective cohort study in urban public health facilities in EthiopiaGetasew Sisay Mihretie, Solomon Mekonnen Abebe, Yeshiwas Abebaw, et al.
European Journal of Heart Failure|January 31, 2017
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trialBiniyam G Demissei, Gad Cotter, Margaret F Prescott, et al.
Pageof 131

Showing results (1001-1010 of 1,306) with videos related to

Sort By:
Pageof 131
Journal of the American Heart Association|May 6, 2021
Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection FractionMelissa A Daubert, Eric Yow, Huiman X Barnhart, et al.
European Journal of Heart Failure|April 29, 2017
Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 studyJohn R Teerlink, Adriaan A Voors, Piotr Ponikowski, et al.
Journal of Cardiac Failure|August 6, 2013
Biomarker-guided therapies in heart failure: a forum for unified strategiesMona Fiuzat, Christopher M O'Connor, Francois Gueyffier, et al.
Circulation. Heart Failure|June 3, 2015
Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart FailureTariq Ahmad, Emily C O'Brien, Phillip J Schulte, et al.
European Journal of Heart Failure|March 7, 2020
Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trialSatit Janwanishstaporn, Siting Feng, John Teerlink, et al.
Journal of the American College of Cardiology|October 11, 2014
Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF studyG Michael Felker, John R Teerlink, Javed Butler, et al.
Journal of Neurosurgery|March 9, 2019
A novel proposed grading system for cerebellar arteriovenous malformationsPeyton L Nisson, Salman A Fard, Christina M Walter, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 17, 2021
Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT TrialFouad Chouairi, Justin Pacor, P Elliott Miller, et al.
BMJ Open|August 2, 2022
Factors associated with discontinuation among long-acting reversible contraceptive users: a multisite prospective cohort study in urban public health facilities in EthiopiaGetasew Sisay Mihretie, Solomon Mekonnen Abebe, Yeshiwas Abebaw, et al.
European Journal of Heart Failure|January 31, 2017
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trialBiniyam G Demissei, Gad Cotter, Margaret F Prescott, et al.
Pageof 131